Stifel Nicolaus initiates coverage on Human Genome Sciences (Nasdaq: HGSI) with a Buy rating and $18 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE